NHS Cancer Nurses Face Toxic Chemical Exposure Risk Due to Inadequate PPE

Cancer nurses in the UK’s National Health Service (NHS) are facing a serious and underreported health crisis: exposure to toxic chemicals used in chemotherapy and other treatments, which may be linked to miscarriages and infertility. An investigation by The Independent and Channel 4 News reveals that tens of thousands of healthcare workers routinely administer hazardous drugs—including those for rheumatoid arthritis, HIV, and multiple sclerosis—while wearing only basic personal protective equipment (PPE) such as plastic aprons and gloves.

The lack of adequate protection puts NHS staff at risk of absorbing these chemicals through inhalation, skin contact, or accidental spills, according to health and safety guidelines. The consequences can be severe, including miscarriage, birth defects, liver damage, and long-term fertility issues. Last September, the NHS West Midlands Cancer Alliance issued guidance warning that “inadequate control measures” could lead to these very health outcomes, yet many trusts continue to provide only minimal PPE to their staff.

Personal Stories Highlight the Crisis

Alison Simons, a cancer nurse with over two decades of experience, believes her repeated miscarriages may be directly linked to her years of working without proper protection. “When I was giving chemo, all we wore were plastic aprons and gloves to our wrists,” she said. “I experienced three miscarriages, and at first, I didn’t make any link between giving chemotherapy at all. In fact, it was my GP who said you give chemotherapy, don’t you?”

Ms. Simons is not alone. Samantha Toland, a nurse consultant in cancer care for 26 years, also suffered a miscarriage between her two children. She now teaches students and has witnessed firsthand the widespread nature of the problem. “I’ve had colleagues who have had multiple miscarriages, up to six or seven, and had to be off work for most of their pregnancy,” she said. While her current trust provides better protections, she has seen many others where controls remain lacking.

Regulatory and Scientific Context

The risks associated with handling cytotoxic drugs are well-documented. In the United States, the Centers for Disease Control and Prevention (CDC) has issued alerts about these dangers to healthcare workers. Several studies have linked exposure to chemotherapy and other hazardous drugs to infertility and other health issues among medical staff. Despite this evidence, UK guidelines currently allow NHS trusts to provide only the “bare minimum” in terms of PPE, leaving many workers vulnerable.

The Royal College of Nursing has criticized the lack of consistent guidelines for identifying hazardous medicinal products and the inadequate risk assessment process across NHS trusts. The Health and Safety Executive (HSE) is now being urged to review the evidence and take action to ensure that all healthcare workers are adequately protected.

What Comes Next?

With growing evidence of harm and personal accounts from affected nurses, the pressure is mounting on regulators and NHS trusts to implement stricter safety measures. The question remains: how much longer will it take for the necessary changes to be made, and how many more healthcare workers will be affected before action is taken?

For now, the health and safety of NHS cancer nurses—and the patients they serve—hangs in the balance, as the fight for adequate protection continues.